Vanda Pharmaceuticals (VNDA) Current Assets (2010 - 2026)

Vanda Pharmaceuticals' Current Assets history runs 17 years deep, the most recent figure standing at $293.2 million for Q1 2026.

• In Q1 2026, Current Assets fell 28.13% year-over-year to $293.2 million; the TTM figure through Mar 2026 stood at $293.2 million (down 28.13% YoY), while the FY2025 annual figure was $347.3 million, down 20.88% from the prior year.
• Current Assets came in at $293.2 million for Q1 2026 at Vanda Pharmaceuticals, down from $347.3 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $536.6 million in Q3 2023 to a low of $293.2 million in Q1 2026.
• A 5-year average of $447.8 million and a median of $439.2 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets climbed 16.87% in 2022 and retreated 28.13% in 2026, its largest moves.
• Vanda Pharmaceuticals' Current Assets stood at $519.3 million in 2022, then fell by 16.63% to $432.9 million in 2023, then increased by 1.37% to $438.9 million in 2024, then fell by 20.88% to $347.3 million in 2025, then decreased by 15.58% to $293.2 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $293.2 million, $347.3 million, and $367.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison